234 related articles for article (PubMed ID: 28659496)
1. Secretion of interleukin-6 by bone marrow mesenchymal stem cells promotes metastasis in hepatocellular carcinoma.
Mi F; Gong L
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28659496
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered bone marrow-derived mesenchymal stem cells co-expressing IFN-γ and IL-10 inhibit hepatocellular carcinoma by modulating MAPK pathway.
Wang H; Wang J; Shi X; Ding Y
J BUON; 2017; 22(6):1517-1524. PubMed ID: 29332347
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
[TBL] [Abstract][Full Text] [Related]
5. Interferon-α2b gene-modified human bone marrow mesenchymal stem cells inhibit hepatocellular carcinoma by reducing the Notch1 levels.
Su Y; Cheng R; Zhang J; Qian J; Diao C; Ran J; Zhang H; Li L
Life Sci; 2015 Dec; 143():18-26. PubMed ID: 26518164
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
7. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
Lee S; Lee M; Kim JB; Jo A; Cho EJ; Yu SJ; Lee JH; Yoon JH; Kim YJ
Biochem Biophys Res Commun; 2016 May; 473(4):1247-1254. PubMed ID: 27091428
[TBL] [Abstract][Full Text] [Related]
8. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible gene 2 promotes the immune escape of hepatocellular carcinoma from nature killer cells through the interleukin-10-STAT3 signaling pathway.
Cui C; Fu K; Yang L; Wu S; Cen Z; Meng X; Huang Q; Xie Z
J Exp Clin Cancer Res; 2019 May; 38(1):229. PubMed ID: 31142329
[TBL] [Abstract][Full Text] [Related]
10. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM
Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX
Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848
[TBL] [Abstract][Full Text] [Related]
12. MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma.
Ding S; Chen G; Zhang W; Xing C; Xu X; Xie H; Lu A; Chen K; Guo H; Ren Z; Zheng S; Zhou L
J Transl Med; 2015 Jul; 13():237. PubMed ID: 26198300
[TBL] [Abstract][Full Text] [Related]
13. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between bone marrow-derived myofibroblasts and gastric cancer cells regulates cancer stemness and promotes tumorigenesis.
Zhu L; Cheng X; Shi J; Jiacheng L; Chen G; Jin H; Liu AB; Pyo H; Ye J; Zhu Y; Wang H; Chen H; Fang J; Cai L; Wang TC; Yang CS; Tu SP
Oncogene; 2016 Oct; 35(41):5388-5399. PubMed ID: 27109105
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells.
Pelagalli A; Nardelli A; Fontanella R; Zannetti A
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409610
[TBL] [Abstract][Full Text] [Related]
16. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
Liu X; Zhang A; Xiang J; Lv Y; Zhang X
Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells.
Ara T; Song L; Shimada H; Keshelava N; Russell HV; Metelitsa LS; Groshen SG; Seeger RC; DeClerck YA
Cancer Res; 2009 Jan; 69(1):329-37. PubMed ID: 19118018
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Stellate Cells Contribute to the Tumor Malignancy of Hepatocellular Carcinoma Through the IL-6 Pathway.
Iwahasi S; Rui F; Morine Y; Yamada S; Saito YU; Ikemoto T; Imura S; Shimada M
Anticancer Res; 2020 Feb; 40(2):743-749. PubMed ID: 32014916
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo.
Zhang J; Hou L; Wu X; Zhao D; Wang Z; Hu H; Fu Y; He J
Mol Cell Biochem; 2016 May; 416(1-2):193-203. PubMed ID: 27142531
[TBL] [Abstract][Full Text] [Related]
20. Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway.
Xie C; Xie DY; Lin BL; Zhang GL; Wang PP; Peng L; Gao ZL
Br J Cancer; 2013 Sep; 109(5):1198-205. PubMed ID: 23887606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]